VD Johan Inborr på PFK-dagen

PEPTONIC Medicals receptfria gel Vagivital ska prissättas i premiumsegmentet. Det berättade bolagets vd Johan Inborr under sin presentation vid PFK-dagen som anordnas den 21/11.

Titta på presentationen »

Johan Inborr på Stora Aktiedagen

Den 13 november arrangerade Aktiespararna Stora Aktiedagen i Stockholm. Peptonics VD Johan Inborr presenterade bolaget och dess planer framåt.

Titta på presentationen »

VD Johan Inborr på Analysguiden

Den 30 maj berättade VD Johan Inborr om bolagets planer på Analysguiden.

Titta på presentationen »

CE-marked non-prescription vaginal gel next goal for Peptonic Medical

Stockholm April 19th, 2017
The Board of Directors of Peptonic Medical AB (publ) (Peptonic or Company) today announced the decision to commence the process of obtaining CE-marking for the vaginal gel that was used as a placebo in a recently completed 2b study conducted by the Company. Once the CE-mark has been obtained, the Company intends to launch the product as a non-prescription option for relief of the symptoms of vaginal atrophy (e.g. dryness, irritation and itching).

Read more »